Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors (LDTam)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2016 by University of Alabama at Birmingham
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
University Health Network, Toronto
University of Michigan
Dana-Farber Cancer Institute
Mayo Clinic
University of Washington
City of Hope National Medical Center
M.D. Anderson Cancer Center
University of Chicago
University of Minnesota - Clinical and Translational Science Institute
University of Colorado, Denver
Wake Forest University
Information provided by (Responsible Party):
University of Alabama at Birmingham Identifier:
First received: September 3, 2010
Last updated: May 14, 2016
Last verified: May 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2019
  Estimated Primary Completion Date: September 2018 (Final data collection date for primary outcome measure)